{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/32.1-331.14.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/32.1-331.14.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/32.1-331.14.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/32.1-331.14.html"}],"law_id":84478,"edition_id":1,"section_id":84478,"structure_id":16038,"section_number":"32.1-331.14","catch_line":"Duties of the Committee","history":"1993, c. 537.","full_text":"A\n\nThe Committee shall make recommendations to the Board regarding drugs or categories of drugs to be subject to prior authorization and prior authorization requirements for prescription drug coverage under the state plan, as well as any subsequent amendments to or revisions of such prior authorization requirements from time to time. The Board may accept or reject such recommendations in whole or in part, and may amend or add to such recommendations, except that the Board may not add to the recommendation of drugs and categories of drugs to be subject to prior authorization.B\n\nIn formulating its recommendations to the Board, the Committee shall not be deemed to be formulating regulations for the purposes of the Administrative Process Act (§ 2.2-4000 et seq.). The Committee shall, however, conduct public hearings prior to making such recommendations to the Board. The Committee shall give thirty days’ written notice by mail of the time and place of its hearings and meetings to any manufacturer whose product is being reviewed by the Committee and to those manufacturers who request the Committee in writing that they be informed of such hearings and meetings. Such persons shall be afforded a reasonable opportunity to be heard and present information. In addition, the Committee shall give thirty days’ notice of such public hearings to the public by publishing its intention to conduct hearings and meetings in the Calendar of Events of the Virginia Register of Regulations and a newspaper of general circulation located in Richmond.C\n\nIn acting on the recommendations of the Committee, the Board shall be required to conduct further proceedings under the Administrative Process Act.","order_by":null,"text":{"0":{"id":302791,"text":"The Committee shall make recommendations to the Board regarding drugs or categories of drugs to be subject to prior authorization and prior authorization requirements for prescription drug coverage under the state plan, as well as any subsequent amendments to or revisions of such prior authorization requirements from time to time. The Board may accept or reject such recommendations in whole or in part, and may amend or add to such recommendations, except that the Board may not add to the recommendation of drugs and categories of drugs to be subject to prior authorization.","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"B"},"1":{"id":302792,"text":"In formulating its recommendations to the Board, the Committee shall not be deemed to be formulating regulations for the purposes of the Administrative Process Act (§ 2.2-4000 et seq.). The Committee shall, however, conduct public hearings prior to making such recommendations to the Board. The Committee shall give thirty days’ written notice by mail of the time and place of its hearings and meetings to any manufacturer whose product is being reviewed by the Committee and to those manufacturers who request the Committee in writing that they be informed of such hearings and meetings. Such persons shall be afforded a reasonable opportunity to be heard and present information. In addition, the Committee shall give thirty days’ notice of such public hearings to the public by publishing its intention to conduct hearings and meetings in the Calendar of Events of the Virginia Register of Regulations and a newspaper of general circulation located in Richmond.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A","next_prefix":"C"},"2":{"id":302793,"text":"In acting on the recommendations of the Committee, the Board shall be required to conduct further proceedings under the Administrative Process Act.","type":"section","prefixes":["C"],"prefix":"C","entire_prefix":"C","prefix_anchor":"C","level":1,"prior_prefix":"B"}},"ancestry":[{"id":16038,"edition_id":1,"name":"Medicaid Prior Authorization Advisory Committee","identifier":"4","label":"article","depth":3,"order_by":1,"parent_id":13275,"metadata":{},"date_created":"2026-06-26 04:04:29","date_modified":"2026-06-26 04:04:29","permalink":{"id":201541,"object_type":"structure","relational_id":16038,"identifier":"4","token":"32.1\/10\/4","url":"\/32.1\/10\/4\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13275,"edition_id":1,"name":"Department of Medical Assistance Services","identifier":"10","label":"chapter","depth":2,"order_by":1,"parent_id":12727,"metadata":{},"date_created":"2026-06-26 03:44:33","date_modified":"2026-06-26 03:44:33","permalink":{"id":201353,"object_type":"structure","relational_id":13275,"identifier":"10","token":"32.1\/10","url":"\/32.1\/10\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12727,"edition_id":1,"name":"Health","identifier":"32.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:50","date_modified":"2026-06-26 03:43:50","permalink":{"id":201099,"object_type":"structure","relational_id":12727,"identifier":"32.1","token":"32.1","url":"\/32.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":70519,"structure_id":16038,"section_number":"32.1-331.12","catch_line":"Definitions","url":"\/32.1-331.12\/","token":"32.1\/10\/4\/32.1-331.12","metadata":false},{"id":64553,"structure_id":16038,"section_number":"32.1-331.13","catch_line":"Medicaid Prior Authorization Advisory Committee; membership","url":"\/32.1-331.13\/","token":"32.1\/10\/4\/32.1-331.13","metadata":false},{"id":84478,"structure_id":16038,"section_number":"32.1-331.14","catch_line":"Duties of the Committee","url":"\/32.1-331.14\/","token":"32.1\/10\/4\/32.1-331.14","metadata":false},{"id":80759,"structure_id":16038,"section_number":"32.1-331.15","catch_line":"Prior authorization of prescription drug products; coverage under state plan","url":"\/32.1-331.15\/","token":"32.1\/10\/4\/32.1-331.15","metadata":false},{"id":74971,"structure_id":16038,"section_number":"32.1-331.16","catch_line":"Immunity","url":"\/32.1-331.16\/","token":"32.1\/10\/4\/32.1-331.16","metadata":false},{"id":62900,"structure_id":16038,"section_number":"32.1-331.17","catch_line":"Annual report to Joint Commission","url":"\/32.1-331.17\/","token":"32.1\/10\/4\/32.1-331.17","metadata":false}],"previous_section":{"id":64553,"structure_id":16038,"section_number":"32.1-331.13","catch_line":"Medicaid Prior Authorization Advisory Committee; membership","url":"\/32.1-331.13\/","token":"32.1\/10\/4\/32.1-331.13","metadata":false},"next_section":{"id":80759,"structure_id":16038,"section_number":"32.1-331.15","catch_line":"Prior authorization of prescription drug products; coverage under state plan","url":"\/32.1-331.15\/","token":"32.1\/10\/4\/32.1-331.15","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/32.1-331.14\/","history_text":"

This law was first created in 1993. The record of its establishment is cataloged in chapter 537 of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year. Unfortunately, the 1993 \u201cActs\u201d aren\u2019t available online.<\/p>","references":false,"refers_to":[{"id":86911,"section_number":"2.2-4000","catch_line":"Short title; purpose","order_by":null,"url":"\/2.2-4000\/"}],"permalink":{"id":201551,"object_type":"law","relational_id":84478,"identifier":"32.1-331.14","token":"32.1\/10\/4\/32.1-331.14","url":"\/32.1-331.14\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/32.1-331.14\/","token":"32.1\/10\/4\/32.1-331.14","dublin_core":{"Title":"Duties of the Committee","Type":"Text","Format":"text\/html","Identifier":"\u00a7 32.1-331.14","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> The Committee<\/span> shall make recommendations to the Board<\/span> regarding drugs or categories of drugs to be subject to prior authorization and prior authorization requirements for prescription drug coverage under the state plan, as well as any subsequent amendments to or revisions of such prior authorization requirements from time to time. The Board<\/span> may accept or reject such recommendations in whole or in part, and may amend<\/span> or add to such recommendations, except that the Board<\/span> may not add to the recommendation of drugs and categories of drugs to be subject to prior authorization. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> In formulating its recommendations to the Board<\/span>, the Committee<\/span> shall not be deemed to be formulating regulations for the purposes of the Administrative Process Act (§ 2.2-4000<\/a> et seq.). The Committee<\/span> shall, however, conduct public hearings<\/span> prior to making such recommendations to the Board<\/span>. The Committee<\/span> shall give thirty days’ written notice by mail of the time and place of its hearings<\/span> and meetings to any manufacturer whose product is being reviewed by the Committee<\/span> and to those manufacturers who request the Committee<\/span> in writing that they be informed of such hearings<\/span> and meetings. Such persons<\/span> shall be afforded a reasonable opportunity to be heard and present information. In addition, the Committee<\/span> shall give thirty days’ notice of such public hearings<\/span> to the public by publishing its intention to conduct hearings<\/span> and meetings in the Calendar of Events of the Virginia Register of Regulations and a newspaper of general circulation located in Richmond. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

C.<\/span> In acting on the recommendations of the Committee<\/span>, the Board<\/span> shall be required to conduct further proceedings under the Administrative Process Act. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nDUTIES OF THE COMMITTEE (\u00a7 32.1-331.14)\n\nA. The Committee shall make recommendations to the Board regarding drugs or\ncategories of drugs to be subject to prior authorization and prior authorization\nrequirements for prescription drug coverage under the state plan, as well as any\nsubsequent amendments to or revisions of such prior authorization requirements\nfrom time to time. The Board may accept or reject such recommendations in whole\nor in part, and may amend or add to such recommendations, except that the Board\nmay not add to the recommendation of drugs and categories of drugs to be subject\nto prior authorization.\n\nB. In formulating its recommendations to the Board, the Committee shall not be\ndeemed to be formulating regulations for the purposes of the Administrative\nProcess Act (§ 2.2-4000 et seq.). The Committee shall, however, conduct\npublic hearings prior to making such recommendations to the Board. The Committee\nshall give thirty days’ written notice by mail of the time and place of\nits hearings and meetings to any manufacturer whose product is being reviewed by\nthe Committee and to those manufacturers who request the Committee in writing\nthat they be informed of such hearings and meetings. Such persons shall be\nafforded a reasonable opportunity to be heard and present information. In\naddition, the Committee shall give thirty days’ notice of such public\nhearings to the public by publishing its intention to conduct hearings and\nmeetings in the Calendar of Events of the Virginia Register of Regulations and a\nnewspaper of general circulation located in Richmond.\n\nC. In acting on the recommendations of the Committee, the Board shall be\nrequired to conduct further proceedings under the Administrative Process Act.\n\nHISTORY: 1993, c. 537.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}